학술논문
A randomized trial of cyclophosphamide, methotrexate, and fluorouracil (CMF) versus methotrexate, fluorouracil (MF) adjuvant chemotherapy in moderate risk breast cancer patients: results after a median follow-up of 7.2 years
Document Type
News
Source
NCI Cancer Weekly. August 13, 1990, p15, 1 p.
Subject
Language
ISSN
0896-7385
Abstract
Complete title: A Randomized Trial of Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Methotrexate, Fluorouracil (MF) Adjuvant Chemotherapy in Moderate Risk Breast Cancer Patients: Results after a Median Follow-Up of 7.2 [...]